Opinions
Jim Cramer - Mad Money
Abiomed
ABMD-Q
BUY
Mar 28, 2022
Medical device-makers are safe in a weakening economy. Shares have soared over the past 12 years by 1,350%. The pandemic caused a big delay in surgeries, but it's now time for ABMD to shine. Their products (treating heart disease) are in high demand. Their most recent quarter was really good. True, this stock isn't cheap, but not neither are their peers.
$321.810
Stock price when the opinion was issued
Healthcare
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
Advertising